Amundi
VIR icon

Amundi’s Vir Biotechnology VIR Stock Holding History

Amundi’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,315
Closed -$137K – 2178
2026
Q1 		$137K Buy
15,315
+5,294
+53% +$42.2K ﹤0.01% 1930
2025
Q4 		$60.4K Sell
10,021
-4,559
-31% -$27.1K ﹤0.01% 1826
2025
Q3 		$81.5K Hold
14,580
– – ﹤0.01% 1588
2025
Q2 		$79.2K Sell
14,580
-22,052
-60% -$118K ﹤0.01% 1654
2025
Q1 		$218K Sell
36,632
-9,982
-21% -$88.8K ﹤0.01% 1662
2024
Q4 		$582K Buy
46,614
+32,241
+224% +$254K ﹤0.01% 1536
2024
Q3 		$105K Buy
14,373
+1,506
+12% +$13.1K ﹤0.01% 1769
2024
Q2 		$113K Sell
12,867
-2,413
-16% -$23.1K ﹤0.01% 1689
2024
Q1 		$122K Buy
15,280
+4,417
+41% +$45K ﹤0.01% 1733
2023
Q4 		$111K Hold
10,863
– – ﹤0.01% 1757
2023
Q3 		$90.9K Buy
10,863
+1,100
+11% +$15.7K ﹤0.01% 1772
2023
Q2 		$240K Buy
+9,763
New +$245K ﹤0.01% 1559
2022
Q4 		– Sell
-3,842
Closed -$85K – 1986
2022
Q3 		$85K Hold
3,842
– – ﹤0.01% 1585
2022
Q2 		$110K Hold
3,842
– – ﹤0.01% 1433
2022
Q1 		$88K Hold
3,842
– – ﹤0.01% 1487
2021
Q4 		$145K Hold
3,842
– – ﹤0.01% 1524
2021
Q3 		$167K Hold
3,842
– – ﹤0.01% 1460
2021
Q2 		$182K Buy
+3,842
New +$175K ﹤0.01% 1393

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Amundi's VIR Position: Q2 2026 in Review

Amundi sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 15,315 shares — an estimated $137K sold.

Amundi first reported a position in VIR in Q2 2021 and held it in 18 quarters. The position peaked at $582K in Q4 2024. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Amundi reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Amundi sold 15,315 Vir Biotechnology shares in Q2 2026, an estimated $137K.
  • Amundi first reported a position in Vir Biotechnology in Q2 2021 and held it in 18 quarters.
  • Amundi's Vir Biotechnology position peaked at $582K in Q4 2024.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.